Antonio Solana-Altabella

23PUBLICATIONS
77CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsOtorhinolaryngologyMedical infection agents (incl. prions)Cardiovascular medicine and haematology not elsewhere classifiedNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 08, 2026
Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA study.

|Apr 22, 2026
Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study.

|Apr 10, 2026
Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry.

Juan M Alonso-Dominguez, Tamara Castaño-Bonilla, Cristina Gil

|Sep 13, 2025
Healthcare Resource Utilization and Treatment Costs for Blastic Plasmacytoid Dendritic Cell Neoplasm: A PETHEMA Study.

Antonio Solana-Altabella, Irene Navarro-Vicente, Eduardo Rodríguez-Arbolí

|Aug 30, 2025
Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia.

Antonio Solana-Altabella, Carles Iniesta-Navalón, Maria Chovi-Trull

|Aug 14, 2025
Cardiotoxicity in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia.

Laura Torres-Miñana, Blanca Boluda, Antonio Solana-Altabella

Pageof 4

Frequent Collaborators

15 joint publications

David Martínez-Cuadrón

15 joint publications

Pau Montesinos

12 joint publications

Juan Eduardo Megías-Vericat

7 joint publications

Octavio Ballesta-López